(Q47303858)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17260365%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

title

Randomized, placebo-controlled trial of low molecular weight heparin in active ulcerative colitis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17260365%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

1 reference

placebo-controlled trial

1 reference

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17260365%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

author name string

M A de Bièvre

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17260365%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

A A Vrij

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17260365%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

E J Schoon

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17260365%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

G Dijkstra

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17260365%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

A E de Jong

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17260365%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

A H Oberndorff-Klein Woolthuis

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17260365%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

R W Stockbrügger

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17260365%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

publication date

1 June 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17260365%20AND%20SRC:MED&resulttype=core&format=json

Inflammatory Bowel Diseases

24 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17260365%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17260365%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17260365%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

page(s)

753-758

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17260365%20AND%20SRC:MED&resulttype=core&format=json

Treatment of corticosteroid-resistant ulcerative colitis with heparin--a report of 16 cases.

24 December 2019

cites work

1 reference

Low-dose low-molecular weight heparin (enoxaparin) is effective as adjuvant treatment in active ulcerative colitis: an open trial

21 January 2018

1 reference

Low molecular weight heparin as adjuvant therapy in active ulcerative colitis

21 January 2018

1 reference

Cyclosporine in severe ulcerative colitis refractory to steroid therapy

21 January 2018

1 reference

Use of enoxaparin in patients with heparin-induced thrombocytopenia syndrome

21 January 2018

1 reference

Ligand binding by fibroblast growth factor receptors investigated using chimeric receptor molecules

21 January 2018

1 reference

Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation

21 January 2018

1 reference

Low molecular weight heparin (tinzaparin) vs. placebo in the treatment of mild to moderately active ulcerative colitis.

21 January 2018

1 reference

Inherited disorders of coagulation appear to protect against inflammatory bowel disease

21 January 2018

1 reference